Q1 2025 · 13F-HR/A
Altium Capital Management LLCholdings as filed
Filed 2025-05-13 · accession 0001420506-25-000988
$41.5M
Reported value
24
Positions
2025-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 488445206 | ZVRA | ZEVRA THERAPEUTICS INC | $9.6M | 23.2% | 1,287,333 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $6.8M | 16.3% | 25,000 | PUT | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $3.6M | 8.59% | 296,193 | Common | SOLE |
| 98420P308 | XTNT | XTANT MED HLDGS INC | $3.4M | 8.21% | 7,252,998 | Common | SOLE |
| G29687103 | AVDL | AVADEL PHARMACEUTICALS PLC | $3.3M | 7.91% | 419,131 | Common | SOLE |
| 21217B100 | CTNM | CONTINEUM THERAPEUTICS INC | $2.1M | 5.11% | 303,857 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MED CORP | $2.1M | 5.06% | 360,589 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $2.0M | 4.87% | 60,251 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $1.7M | 4.00% | 1,050,369 | Common | SOLE |
| 83086J200 | SKYE | SKYE BIOSCIENCE INC | $1.4M | 3.47% | 904,865 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $897,725 | 2.16% | 177,416 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $881,452 | 2.12% | 303,949 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $714,938 | 1.72% | 1,051,379 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $613,664 | 1.48% | 168,589 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $587,389 | 1.42% | 273,204 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $399,389 | 0.96% | 574,248 | Common | SOLE |
| 29415J106 | — | ENVVENO MEDICAL CORPORATION | $324,163 | 0.78% | 123,256 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $315,370 | 0.76% | 9,400 | CALL | SOLE |
| 36151G600 | GBS1EUR | INTELLIGENT BIO SOLUTIONS IN | $214,923 | 0.52% | 149,252 | Common | SOLE |
| 48576U205 | KPTI | KARYOPHARM THERAPEUTICS INC | $184,505 | 0.44% | 49,333 | Common | SOLE |
| 82003F200 | — | SHARPS TECHNOLOGY INC | $110,405 | 0.27% | 4,044,149 | Common | SOLE |
| 67091J602 | — | LOGICMARK INC | $106,827 | 0.26% | 5,395,308 | Common | SOLE |
| 867781700 | SBFM | SUNSHINE BIOPHARMA INC | $96,390 | 0.23% | 50,466 | Common | SOLE |
| 08771Y402 | SRXH | BETTER CHOICE CO INC | $67,052 | 0.16% | 38,984 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.